Barton B E, WoldeMussie E, Wheeler L
Department of Biochemistry, Allergan Inc., Irvine, CA 92715.
Immunopharmacol Immunotoxicol. 1988;10(1):35-52. doi: 10.3109/08923978809014400.
The role of arachidonic acid metabolites as second messengers in the IL-3-induced activation of DA-1 cells was examined. By using inhibitors of either the cyclooxygenase (CO) or lipoxygenase (LPO) pathways, we determined that neither prostaglandins nor leukotrienes were involved in signal transduction, since aspirin, indomethacin, meclofenamic acid, and nordihydroguaiaretic acid (NDGA) failed to inhibit the proliferation response of DA-1 cells to IL-3. Furthermore, two combination CO/LPO inhibitors, benoxaprofen and BW755c, failed to inhibit DA-1 proliferation. A new CO/LPO compound examined, SK&F 86002, did inhibit proliferation (IC50 = 30 microM +/- 14, N = 11), leading us to conclude this drug has other actions besides CO/LPO inhibition. Finally, direct measurement of 3H-arachidonic acid uptake by DA-1 cells failed to show a difference in the amount of 3H-arachidonic acid incorporated in the presence of limiting or saturating amounts of IL-3. We conclude from these data that arachidonic acid metabolites are not involved in transmembrane signalling by IL-3 in DA-1 cells.
研究了花生四烯酸代谢产物作为第二信使在白细胞介素-3(IL-3)诱导的DA-1细胞激活过程中的作用。通过使用环氧化酶(CO)或脂氧化酶(LPO)途径的抑制剂,我们确定前列腺素和白三烯均不参与信号转导,因为阿司匹林、吲哚美辛、甲氯芬那酸和去甲二氢愈创木酸(NDGA)未能抑制DA-1细胞对IL-3的增殖反应。此外,两种联合的CO/LPO抑制剂,苯恶洛芬和BW755c,也未能抑制DA-1细胞的增殖。一种新检测的CO/LPO化合物SK&F 86002确实抑制了增殖(半数抑制浓度[IC50]=30微摩尔±14,N=11),这使我们得出结论,该药物除了抑制CO/LPO外还有其他作用。最后,对DA-1细胞摄取3H-花生四烯酸的直接测量结果显示,在存在限量或饱和量IL-3的情况下,掺入的3H-花生四烯酸量没有差异。从这些数据我们得出结论,花生四烯酸代谢产物不参与IL-3在DA-1细胞中的跨膜信号传导。